Dianthus Therapeutics, Inc. (XETR:87E) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Thomas Daniel Other companies: Gossamer Bio, Inc. (Director · Since at least Feb 7, 2019); Larimar Therapeutics, Inc. (Director · Mar 3, 2016 – May 12, 2021 · Past); Juno Therapeutics Inc (Director · Aug 11, 2015 – Mar 5, 2018 · Past); Epizyme Inc (Director · May 30, 2013 – May 30, 2013 · Past); Celgene Corporation (see remarks · Feb 15, 2012 – Dec 31, 2015 · Past) | Director · Jun 20, 2018 – Jun 28, 2022 · Past |
| Bruce Booth Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Vigil Neuroscience Inc (Director · Since at least Jan 6, 2022); Kymera Therapeutics, Inc. (Director · Since at least Mar 12, 2021); Tectonic Therapeutic, Inc. (Director · Jun 10, 2021 – Jun 6, 2023 · Past) | Director · Jun 1, 2021 – Jun 28, 2022 · Past |
| Leon O Moulder Jr Other companies: Zenas BioPharma, Inc. (See Remarks, Director · Since at least Sep 12, 2024); Zai Lab Ltd. (Director · Since at least Jan 1, 2021); Trevena, Inc. (Director · May 16, 2018 – Jun 15, 2023 · Past); Tesaro Inc (Chief Executive Officer, Director · Mar 1, 2018 – Jan 22, 2019 · Past) | Director · Sep 11, 2023 – May 23, 2024 · Past |
| Jason Ryan Other companies: GeneDx Holdings Corp. (Director · Since at least Jul 22, 2021); Singular Genomics Systems Inc (Director · May 26, 2021 – Feb 21, 2025 · Past); Foundation Medicine Inc (Chief Financial Officer · Sep 24, 2013 – Jul 31, 2018 · Past) | See Remarks · Jan 1, 2019 – Feb 10, 2020 · Past |
| Jeffrey Humphrey Other companies: Lantheus Holdings, Inc. (Chief Medical Officer · May 28, 2024 – Jun 17, 2024 · Past); Cyteir Therapeutics Inc (Director · Dec 15, 2021 – Feb 3, 2023 · Past); Constellation Pharmaceuticals Inc (Chief Medical Officer · Jun 22, 2020 – Jul 15, 2021 · Past) | Chief Medical Officer · Oct 1, 2021 – Aug 1, 2022 · Past |
| Adam Veness Other companies: Cyteir Therapeutics Inc (General Counsel · Apr 25, 2022 – Feb 3, 2023 · Past); Acceleron Pharma Inc (SVP, General Counsel and Sec. · Jan 4, 2021 – Nov 19, 2021 · Past) | General Counsel · Since at least Sep 11, 2023 |
| Marino Garcia Other companies: AgomAb Therapeutics NV (Director · Since at least Sep 11, 2026); Synergy Pharmaceuticals Inc (EVP and Chief Strategy Officer · Jan 5, 2018 – Jan 5, 2018 · Past) | President & Chief Executive Officer, Board Member · Since at least Sep 11, 2023 |
| Steven J Romano Other companies: Silence Therapeutics PLC (EVP and Chief R&D Officer · Since at least Jan 2, 2025); Mallinckrodt Inc (EVP & Chief Sci. Ofcr · Jun 16, 2022 – Jun 16, 2022 · Past) | Director · Since at least Sep 16, 2024 |
| Sujay Kango Other companies: Lite Strategy, Inc. (Director · Nov 22, 2021 – Sep 29, 2023 · Past); Acceleron Pharma Inc (EVP, Chief Commercial Officer · Feb 12, 2018 – Nov 19, 2021 · Past) | Director · Since at least Mar 4, 2025 |
| Amy Ronneberg Other companies: Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024) | Director · Jun 20, 2018 – Jun 28, 2022 · Past |
| Cindy Driscoll Other companies: Climb Bio, Inc. (Senior Vice President, Finance · Since at least Jun 17, 2025) | See Remarks · Jun 20, 2018 – Oct 1, 2020 · Past |
| Edward Carr Other companies: Abeona Therapeutics Inc. (Chief Financial Officer · Nov 9, 2018 – Oct 8, 2021 · Past) | Chief Accounting Officer · Since at least Sep 11, 2023 |
| Paula Soteropoulos Other companies: Rallybio Corporation (Lead Independent Director · Since at least May 13, 2025) | Director · Since at least May 22, 2025 |
| David Wayne Nichols | Chief Technical Officer · May 17, 2022 – Aug 1, 2022 · Past |
| Jason Gardner | See Remarks, Director · Jun 20, 2018 – Nov 30, 2022 · Past |
| Jennifer Davis Ruff | Head of Investor Relations and Corporate Affairs · Since at least Nov 4, 2026 |
| Lisa Olson | See Remarks · Sep 14, 2020 – Aug 1, 2022 · Past |
| Michael David Gregory | Director · Jan 22, 2024 – Jan 22, 2024 · Past |
| Ryan Savitz | Executive Vice President, Chief Financial Officer & Chief Business Officer · Since at least Mar 31, 2026 |
| Simon Read | Director · Since at least May 22, 2025 |
| Simrat Randhawa | Executive Vice President, Head of R&D · Since at least Sep 11, 2023 |